Form of Proxy

Approval of the annual consolidated accounts for the 2025 financial year.

Approval of the annual accounts for the 2025 financial year.

Allocation of 2025 income; setting of the dividend.

Approval of the Statutory Auditors' report on related-party agreements referred to in Article L. 225-38 of the French Commercial Code.

Approval of the remuneration policy for the Chairman of the Board of Directors, pursuant to Article L. 22-10-8 of the French Commercial Code.

Approval of the remuneration policy for the Chief Executive Officer and the Deputy Chief Executive Officer, pursuant to Article L. 22-10-8 of the French Commercial Code.

Approval of the remuneration policy for Directors, pursuant to Article L. 22-10-8 of the French Commercial Code.

Increase in the global annual amount of directors’ remuneration.

Approval of the information relating to the remuneration of each corporate officer required by Article L. 22-10-9 I of the French Commercial Code.

Approval of the components composing the total remuneration and benefits of any kind paid during or awarded to Mr Lorenzo Bini Smaghi, Chairman of the Board of Directors in respect of the 2025 financial year, pursuant to Article L. 22-10-34 II of the French Commercial Code.

Approval of the components composing the total remuneration and benefits of any kind paid during or awarded to Mr Slawomir Krupa, Chief Executive Officer, in respect of the 2025 financial year, pursuant to Article L. 22-10-34 II of the French Commercial Code.

Approval of the components composing the total remuneration and benefits of any kind paid during or awarded to Mr Pierre Palmieri, Deputy Chief Executive Officer, in respect of the 2025 financial year, pursuant to Article L. 22-10-34 II of the French Commercial Code.

Advisory opinion on remuneration paid in 2025 to regulated persons referred to in Article L. 511-71 of the French Monetary and Financial Code.

Ratification of the co-option of Mrs Laura Barlow as Director and renewal of her term of office.

Appointment of Dame Clara Furse as Director, replacing Mr Lorenzo Bini Smaghi’s term of office.

Renewal of Mr Jrme Contamine’s term of office as Director.

Renewal of Mrs Diane Ct’s term of office as Director.

Authorisation granted to the Board of Directors to purchase ordinary shares of the Company up to a limit of 10% of the share capital.

Delegation of authority granted to the Board of Directors in order to increase the share capital, with pre-emptive subscription rights, through the issuance of ordinary shares and/or securities giving access to the share capital of the Company and/or its subsidiaries and/or through incorporation.

Delegation of authority granted to the Board of Directors in order to increase the share capital, with cancellation of pre-emptive subscription rights, per public offer other than the ones referred to in Article L. 411-2, 1o of the French Monetary and Financial Code, through the issuance of ordinary shares and/or securities giving access to the sha

Delegation of authority granted to the Board of Directors to increase the share capital without pre-emptive subscription rights to remunerate contributions in kind granted to the Company.

Delegation of authority granted to the Board of Directors in order to proceed with the issuance of super-subordinated bonds convertible into shares, with cancellation of pre-emptive subscription rights, per public offer referred to in Article L. 411-2, 1o of the French Monetary and Financial Code.

Authorisation granted to the Board of Directors in order to proceed, with cancellation of pre-emptive subscription rights, with share capital increases or sales of shares reserved for eligible persons from entities participating in company or Group employee savings plans, of Societe Generale.

Authorisation granted to the Board of Directors in order to proceed with free allocations of performance shares, existing or to be issued, without pre-emptive subscription rights, for the benefit of the regulated persons referred to in Article L. 511-71 of the French Monetary and Financial Code or assimilated

Authorisation granted to the Board of Directors in order to proceed with free allocations of performance shares, existing or to be issued, without pre-emptive subscription rights, for the benefit of employees other than the regulated persons referred to in Article L. 511-71 of the French Monetary and Financial Code or assimilated.

Authorisation granted to the Board of Directors in order to cancel, within the limit of 10% of its capital per period of 24 months, treasury shares held by the Company.

Amendment of the by-laws to provide that the initial term of office of the co-opted director shall end at the general meeting ratifying the co-option.

Amendment of the by-laws to provide that the candidate for the position of director representing employee shareholders (ARSA) will, in future, be elected with a second replacement of the same gender in order to comply with Order No. 2024-934 of 15 October 2024 transposing Directive (EU) 2022/2381 of the European Parliament and of the Council of 23

Amendment of the by-laws to remove references referring to the possibility for the same person to cumulate the positions of Chairman of the Board of Directors and Chief Executive Officer to take into account Directive (EU) 2024/1619 of the European Parliament and of the Council of 31 May 2024, known as ‘CRD VI’, amending Directive 2013/36/EU as reg

Powers to carry out legal formalities.